Molecular level Interactions of S100A13 with amlexanox

Inhibitor for formation of the multiprotein complex in the nonclassical pathway of acidic fibroblast growth factor

Sandhya Golla, Sepuru K. Mohan, Chin Yu

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

S100A13 and acidic fibroblast growth factor (FGF1) are involved in a wide array of important biological processes, such as angiogenesis, cell differentiation, neurogenesis, and tumor growth. Generally, the biological function of FGF1 is to recognize a specific tyrosine kinase on the cell surface and initiate the cell signal transduction cascade. Amlexanox (2-amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid) is an antiallergic drug that binds S100A13 and FGF1 and inhibits the heat shock induced release of S100A13 and FGF1. In the present study, we investigated the interaction of amlexanox with S100A13 using various biophysical techniques, including isothermal titration calorimetry, fluorescence spectrophotometry, and multidimensional NMR spectroscopy. We report the three-dimensional solution structure of the S100A13-amlexanox complex. These data show that amlexanox binds specifically to the FGF1-S100Al3 interface and prevents the formation of the FGF1-releasing complex. In addition, we demonstrate that amlexanox acts as an antagonist of S100A13 by binding to its FGF1 binding site and subsequently inhibiting the nonclassical pathway of these proteins. This inhibition likely results in the ability of amlexanox to antagonize the angiogenic and mitogenic activity of FGF1.

Original languageEnglish (US)
Pages (from-to)2585-2592
Number of pages8
JournalBiochemistry
Volume49
Issue number11
DOIs
StatePublished - Mar 23 2010
Externally publishedYes

Fingerprint

Fibroblast Growth Factor 1
Multiprotein Complexes
Biological Phenomena
amlexanox
Anti-Allergic Agents
Signal transduction
Calorimetry
Fluorescence Spectrometry
Neurogenesis
Spectrophotometry
Carboxylic Acids
Titration
Protein-Tyrosine Kinases
Nuclear magnetic resonance spectroscopy
Tumors
Cell Differentiation
Shock
Signal Transduction
Magnetic Resonance Spectroscopy
Hot Temperature

ASJC Scopus subject areas

  • Biochemistry

Cite this

Molecular level Interactions of S100A13 with amlexanox : Inhibitor for formation of the multiprotein complex in the nonclassical pathway of acidic fibroblast growth factor. / Golla, Sandhya; Mohan, Sepuru K.; Yu, Chin.

In: Biochemistry, Vol. 49, No. 11, 23.03.2010, p. 2585-2592.

Research output: Contribution to journalArticle

@article{2b8194a5bd214a699284734332b2952f,
title = "Molecular level Interactions of S100A13 with amlexanox: Inhibitor for formation of the multiprotein complex in the nonclassical pathway of acidic fibroblast growth factor",
abstract = "S100A13 and acidic fibroblast growth factor (FGF1) are involved in a wide array of important biological processes, such as angiogenesis, cell differentiation, neurogenesis, and tumor growth. Generally, the biological function of FGF1 is to recognize a specific tyrosine kinase on the cell surface and initiate the cell signal transduction cascade. Amlexanox (2-amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid) is an antiallergic drug that binds S100A13 and FGF1 and inhibits the heat shock induced release of S100A13 and FGF1. In the present study, we investigated the interaction of amlexanox with S100A13 using various biophysical techniques, including isothermal titration calorimetry, fluorescence spectrophotometry, and multidimensional NMR spectroscopy. We report the three-dimensional solution structure of the S100A13-amlexanox complex. These data show that amlexanox binds specifically to the FGF1-S100Al3 interface and prevents the formation of the FGF1-releasing complex. In addition, we demonstrate that amlexanox acts as an antagonist of S100A13 by binding to its FGF1 binding site and subsequently inhibiting the nonclassical pathway of these proteins. This inhibition likely results in the ability of amlexanox to antagonize the angiogenic and mitogenic activity of FGF1.",
author = "Sandhya Golla and Mohan, {Sepuru K.} and Chin Yu",
year = "2010",
month = "3",
day = "23",
doi = "10.1021/bi9019077",
language = "English (US)",
volume = "49",
pages = "2585--2592",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "11",

}

TY - JOUR

T1 - Molecular level Interactions of S100A13 with amlexanox

T2 - Inhibitor for formation of the multiprotein complex in the nonclassical pathway of acidic fibroblast growth factor

AU - Golla, Sandhya

AU - Mohan, Sepuru K.

AU - Yu, Chin

PY - 2010/3/23

Y1 - 2010/3/23

N2 - S100A13 and acidic fibroblast growth factor (FGF1) are involved in a wide array of important biological processes, such as angiogenesis, cell differentiation, neurogenesis, and tumor growth. Generally, the biological function of FGF1 is to recognize a specific tyrosine kinase on the cell surface and initiate the cell signal transduction cascade. Amlexanox (2-amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid) is an antiallergic drug that binds S100A13 and FGF1 and inhibits the heat shock induced release of S100A13 and FGF1. In the present study, we investigated the interaction of amlexanox with S100A13 using various biophysical techniques, including isothermal titration calorimetry, fluorescence spectrophotometry, and multidimensional NMR spectroscopy. We report the three-dimensional solution structure of the S100A13-amlexanox complex. These data show that amlexanox binds specifically to the FGF1-S100Al3 interface and prevents the formation of the FGF1-releasing complex. In addition, we demonstrate that amlexanox acts as an antagonist of S100A13 by binding to its FGF1 binding site and subsequently inhibiting the nonclassical pathway of these proteins. This inhibition likely results in the ability of amlexanox to antagonize the angiogenic and mitogenic activity of FGF1.

AB - S100A13 and acidic fibroblast growth factor (FGF1) are involved in a wide array of important biological processes, such as angiogenesis, cell differentiation, neurogenesis, and tumor growth. Generally, the biological function of FGF1 is to recognize a specific tyrosine kinase on the cell surface and initiate the cell signal transduction cascade. Amlexanox (2-amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid) is an antiallergic drug that binds S100A13 and FGF1 and inhibits the heat shock induced release of S100A13 and FGF1. In the present study, we investigated the interaction of amlexanox with S100A13 using various biophysical techniques, including isothermal titration calorimetry, fluorescence spectrophotometry, and multidimensional NMR spectroscopy. We report the three-dimensional solution structure of the S100A13-amlexanox complex. These data show that amlexanox binds specifically to the FGF1-S100Al3 interface and prevents the formation of the FGF1-releasing complex. In addition, we demonstrate that amlexanox acts as an antagonist of S100A13 by binding to its FGF1 binding site and subsequently inhibiting the nonclassical pathway of these proteins. This inhibition likely results in the ability of amlexanox to antagonize the angiogenic and mitogenic activity of FGF1.

UR - http://www.scopus.com/inward/record.url?scp=77949537772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949537772&partnerID=8YFLogxK

U2 - 10.1021/bi9019077

DO - 10.1021/bi9019077

M3 - Article

VL - 49

SP - 2585

EP - 2592

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 11

ER -